Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Gary Yuk-Fai Lau"'
Autor:
Rubaiyea Farrukee, Celeste Ming-Kay Tai, Ding Yuan Oh, Danielle E Anderson, Vithiagaran Gunalan, Martin Hibberd, Gary Yuk-Fai Lau, Ian G Barr, Veronika von Messling, Sebastian Maurer-Stroh, Aeron C Hurt
Publikováno v:
PLoS Pathogens, Vol 16, Iss 6, p e1008592 (2020)
The neuraminidase (NA) inhibitor (NAI) oseltamivir (OST) is the most widely used influenza antiviral drug. Several NA amino acid substitutions are reported to reduce viral susceptibility to OST in in vitro assays. However, whether there is a correlat
Externí odkaz:
https://doaj.org/article/8077b174301144968624520fb39ef22e
Autor:
Danielle E. Anderson, Martin L. Hibberd, Sebastian Maurer-Stroh, Rubaiyea Farrukee, Ding Yuan Oh, Aeron C. Hurt, Celeste Ming-Kay Tai, Veronika von Messling, Ian G. Barr, Gary Yuk-Fai Lau, Vithiagaran Gunalan
Publikováno v:
PLoS Pathogens, Vol 16, Iss 6, p e1008592 (2020)
PLoS Pathogens
PLoS pathogens, 16(6):e1008592
PLoS Pathogens
PLoS pathogens, 16(6):e1008592
The neuraminidase (NA) inhibitor (NAI) oseltamivir (OST) is the most widely used influenza antiviral drug. Several NA amino acid substitutions are reported to reduce viral susceptibility to OST in in vitro assays. However, whether there is a correlat